Bottom line
What is RCGHX's expense ratio?
RCGHX's expense ratio is 2.16%, or about $216 a year on every $10,000 invested. That is more expensive than 97% of health care sector funds we track (median 0.96%). It has no front-end sales load. Its expense ratio includes a 1% 12b-1 marketing fee.
Updated Oct 22, 2025
RCGHX fee table
| Net expense ratio | 2.16% |
|---|---|
| Gross expense ratio | 2.16% |
| Management fee | 0.8% |
| 12b-1 (distribution) fee | 1% |
| Other expenses | 0.36% |
| Fee waiver / reimbursement | 0% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 1% |
Source: Fund prospectus fee table, filed Oct 22, 2025
What RCGHX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| RCGHX | $319 | $676 | $1,159 | $2,493 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 2.16% expense ratio costs roughly $108,200 in lost growth, versus about $53,400 for the median health care sector fund (0.96%).